Background characteristics of study participants. by Awole Seid (3839965)

Subjects:

Conceptual model derived from interpretations of findings. by Awole Seid (3839965)

Subjects:

Summary of key questions and follow-up probes used in the phenomenological study. by Awole Seid (3839965)

Subjects:

Dataset. by Awole Seid (3839965)

Subjects:

Uronic acid analysis-based screen identified IFA as an effective capsule inhibitor. by Tingting Wang (123983)

Subjects:

IFA did not affect LPS-induced inflammation response. by Tingting Wang (123983)

Subjects:

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

Subjects:

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Subjects:

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

Subjects:

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

Subjects:

IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

Subjects:

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

Subjects:

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

Subjects:

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. by Tingting Wang (123983)

Subjects:

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. by Tingting Wang (123983)

Subjects:

Hyperparameter settings. by Qingnan Ji (22662198)

Addressing Imbalanced Classification Problems in Drug Discovery and Development Using Random Forest, Support Vector Machine, AutoGluon-Tabular, and H2O AutoML by Ayush Garg (21090944)

Subjects:

Effect of 1.25% of SCFP on MDR <i>Salmonella</i> serovars reduction at 24h. by Elena G. Olson (10649705)

Chromatogram results of quantitative and qualitative analysis the PLE. by Xiaoqiang Huang (1457860)

Subjects:

PLE prevents the development of psoriasis by inhibiting the activation of TLR4/NF- κB and PI3K/AKT signaling pathway. by Xiaoqiang Huang (1457860)

Subjects: